Has Vivek Kumbhari, MD received payments from drug or device companies?

Yes. Drug and device makers reported $254,050 in general payments to Vivek Kumbhari, MD across 265 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vivek Kumbhari, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vivek Kumbhari, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vivek Kumbhari, MD

Gastroenterology · Jacksonville, FLNPI 1740522069

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $157,324 of the $254,050 with a category attached, or 61.9%. 21 manufacturers reported payments, led by Apollo Endosurgery US Inc at 25.4% of the total. Reporting peaked in 2019 at $104,682 and has fallen 94.6% since, to $5,603 in 2025. Among gastroenterology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$254,050in general payments, 2019–2025

Across 265 payments — averaging $958.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Apollo Endosurgery US Inc$65K
Fujifilm Healthcare Americas Corporation$35K
Erbe Elektromedizin GmbH$33K
Pentax Of America, Inc.$30K
Covidien LP$26K
Boston Scientific$20K
plus $46K from 15 others

$506,583in research payments, 2019–2025

Across 14 payments — averaging $36,185 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Fujifilm Healthcare Americas Corporation$386K
Erbe Elektromedizin GmbH$104K
Apollo Endosurgery US Inc$17K

What the payments were for

Consulting fees$157,32462%
Speaking & faculty fees$39,75016%
Grants$1,9291%
Travel & lodging$42,50917%
Food & beverage$8,8833%
Education$3,6561%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Apollo Endosurgery US Inc	36	$64,507
Fujifilm Healthcare Americas Corporation	39	$34,562
Erbe Elektromedizin GmbH	2	$33,039
Pentax Of America, Inc.	17	$30,026
Covidien LP	34	$25,518
Boston Scientific	61	$20,446
Medtronic	25	$18,518
Micro-tech Endoscopy USA, Inc.	12	$17,510
ERBE USA Inc	1	$4,891
Cook Medical LLC	3	$2,059
Olympus America Inc.	14	$858
Intuitive Surgical	1	$450
Endogastric Solutions, Inc	4	$418
Ambu Inc.	6	$323
GI Supply, Inc.	1	$300
Creo Medical Inc.	2	$228
Gyrus ACMI, Inc.	2	$178
Novo Nordisk	1	$61
Laborie Medical Technologies Corp.	1	$61
Olympus Corporation Of The Americas	2	$58
Fujifilm New Development USA, Inc.	1	$41

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$254,050 in reported general payments places this provider in the 95th percentile of 1,388 gastroenterology providers in Florida.

See all gastroenterology providers in Florida →

Medicare billing

Part B allowed, 2024

$74,305

Medicare patients

251

Services billed

432

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Jacksonville

Francis FarrayeJacksonville$395K
Jami KinnucanJacksonville$313K
Ali Moghani LankaraniJacksonville$105K
Ana CorregidorJacksonville$79K
Mark FleisherJacksonville$74K
Victoria GomezJacksonville$65K
Samuel GidayOrlando$2M
Lukasz KwapiszMiami$1.2M
Jennifer Seminerio-DiehlOrlando$1.1M
Udayakumar NavaneethanSaint Petersburg$1.1M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →